Syros Pharmaceuticals Inc.

-0.05 (-1.33%)
7:49:43 PM EDT: $3.85 +0.15 (+4.05%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)75.19M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.08 Million
Adjusted EPS-$1.12
See more estimates
10-Day MA$3.77
50-Day MA$3.06
200-Day MA$4.53
See more pivots

Syros Pharmaceuticals Inc. Stock, NASDAQ:SYRS

35 CambridgePark Drive, 4th floor, Cambridge, Massachusetts 02140-2325
United States of America
Phone: +1.617.744.1340
Number of Employees: 117


Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.